Adrian. you, Thank
for to our ongoing quarterly and their long everyone, support shareholders first term welcome like thanks So commitment. and thanking by our start I'd call. to
satisfied that and transformational is some moving we As for this quarterly us we milestones quarter team with as they under the on at on to past now did just solid past on our this can quarter quarter are intensely close recent we our focused year last term keep the very be and particularly preservation. they've had well call. that over a budget executing results we able um some the behind strategy forward and for and and that proud we really are the that discussed so put delivered cash eye long
moving to of investors note providing audio will and more webcast. feedback look the term first we've type our format this that always one I be conference aspired that patent suggested to time would useful the we sure We ongoing make that communications are we for feedback, from including changed have transparent long an we response in that forward so to. of and the call a truly, here did to to
start with and EsoGuard operating in during that we've to We XXX% let X,XXX quarter three has quarter states centers with to due are -- quarter. highlights; eleven this a quarter thirteen quarter test milestone. happy gratified So some that have cleared third open quarterly tests the per quarter and that and coming testing annually in the tests during are more now X,XXX me volume performed we've sequentially increased that we're XX% to this
about been patients undergoing testing. EsoGuard satellite now describe more The LTC concept detail includes and last in activity, and on XX% I'll increasing a rapidly the call of we has introduced that our later, the
in We're that and revenue is Labs quality receive Labs LucidDx August. on starting LucidDx our submitted under claims efficiency recognizing payments laboratory to and view. enhanced EsoGuard in with Our that independently starting operating metrics were
strategy year mentioned, reimbursement support the for of for a We I to well EsoCheck full our we're high of volume focus and and budget running public to and conserving to are We ahead growth that both have manufacturer underway. cash payer clinical and as on continuing transfer past are completed our this while executing private studies on utility the quarters.
company, in is Diagnostics company. prevention prevent tens early commercial at diagnostic with cancer cancers millions gastroesophageal Recent introduction medical learning a chronic chronic heartburn. from and heartburn who either you those mission on are for of We're the reflux just of lethal is these the of patients cancer patients focused our risk stage with about at pre-cancer gastroesophageal and Lucid are who of developing our detection highly risk reflux deaths to these of
Esophageal diagnosis an had common key staged victory. far on is statistics slide, other more you and the Stage breast can lethal cancer XXX% we about XX% The year last remains however, second XX%, mortality. is there. I the patients every cancer in overall and circumstances like most is over cancer all cancer other becoming highly it a increase cancer few years this rate with is the We've a of right got mortality on decades unlike see one prevalent sixteen five actually the where private thousand nearly that colon is most and
is prevent this who X% So these been for recommended a have pre-cancer and decade unfortunately to those early detection really of for screening have because endoscopy. necessary undergone than deaths historically of over less
our the of and tests EsoGuard, Lucid's and widespread only screening device capable a include tool as early through prevent is cell are serving This DNA esophageal products first of EsoCheck pre-cancer. they two detection to these the test esophageal collection our the deaths available commercially products and
prevention are this a cancer merely of in to type for viable missing particular So establishing a they cancer. sense, program
from society and the as a as EsoGuard the really and with EsoCheck longer EsoGuard candidates having consider alternative recommend testing. heartburn announced which symptomatic have the population prerequisite, significantly patients this conjunction in acceptable for who to We're has excited endoscopy gastroenterology an society further previously no updates also we of are mandatory expanded now the that major guidelines
this who represent is who heartburn because but patients expansion patients an are as note should million include mentioned of not the who I to risk, large that chronic Gastroenterology opportunity and the unequivocal in target are include elimination I increase now an for reflect commercial here limit. of does need at symptoms of The guidelines recommended GERD very, does the XX Association the recommendation updated screening. of the very American for have guidelines, population
Medicare large opportunity volume. a resulting multibillion dollar payment been XX% in $X,XXX and has an very growth market margin established over and at estimated cross
so and test. practices, sales well our to care Our now The hospitals surgeons These physicians institutions. [indiscernible] large primary goal include practices, targeting as small talk but channels is to doctors the when includes strategy are gastroenterologists, PCP specialties and somewhat and at EsoGuard different two to, as them specialists forth. institutions, get we
looking esophageal and bringing build another case testing. opportunities them program more revenue EsoGuard have that and create downstream those more to endoscopy -- monitoring patients by making specialties institutions, with an patients with for the more will the pre-cancer patients However, detecting PH with we're that by to
somewhat to procedure The EsoCheck are performed and test There patients sent PCP one the with Lucid institutions. one where also nurse sensors counts have options. are [ph]. cell practitioners our referred of They a Lucid collection practices the different of our two
their trained cell increasingly performs are after who mentioned have where are we're spectacular practitioners have where situations at that or day. the set patients that We patients procedure teed I We own practices up the continuing to up a had a for but this. particular forward up perform expand we're the practice, or day dozen for typically to sense looking to so been allocating utilizing a other where have them, to able also to some physician and assistant nurse beginning, at and as we perform the own test collection practitioner our nurse nurse institutions
where we We challenges have the to the established those and there compliance robust test couple regulation Florida some of have figuring limitations, or California around in satellite being states two, this we're the out and ways compliance centers. program are but around both and states work a
test they that practioners a not which we've are as educational well that Lucid of patients nurse physicians programs centers lot also be around to where are testing, locations centred. established could sort targeting physical centers tend but a of as perform current just are
I've our location performing the the but numbers that line attractive, two We all cover week. economics centers bottom today, procedures as reimburse are the won't test as the through of we very per many of cost times fixed The of well go before. the by as personnel can mentioned is
noted growth, throttle we get in we but we volume, performed So a quarter growth XXX% coming not XX% the see from increase show reimbursement I've second hope in deploying described of quarters. tests full EsoGuard have a the third increase more to metropolitan the until this steady I good [ph] X,XXX testing steady continue the which and XXXX. predictable strategy represents the as coming -- as quarter going in resources quarter, beginning, in the a from sufficient third where are in which we to to
the a I'll been really in also has and in steadily sales of personnel, slide, as increased data our we're and growth processes this So training at we driven next by factors, grow experience. team developing improved increased now dramatically variety we've driven as have our we our sales show
we in Although to rep the increased has improved through to for in only field the extract a the i been existing two field. forward or our will that team look note median performance month experience and continuing from
piece the right are that track being but approximately small or individual still referred PCP recording can optimizing specialists of see and half starting half now generally small by coming patients We're and volume numbers, remainder of the the under patients so are are tracking operator. rough source by -- We institutions. the or individual these testing referral by just these from and to you the are and practices
at on important well variety to moving LTC note slide of expect satellite trend it's in earlier, the the LTC the LTC. that and growth the were from nurse last in done expect the performed our with the And its then quarter thing physician practices, this patients fourth quarter I physician on continue as practitioners noted forward. collocating of is XX% as -- driver now, a adequate model of to nurse the to is be practice practitioners to tests as making settings, we to that clearly in our referred from but or tests a where and it practice test are satellite this being an we perform including performance important and and I the that own impact
shows of slide in sales our This this team. previous expansion showed slides. I've the
progression steady team. month see of we good You making at were our expanding the can
sales reps leadership. XX have full spectrum to senior the on professionals We the sales the of way sales across
plateau look the of intend we've target the would Our target by for where year, this the is early part the XX. quarter that of XXXX. term by first likely to near to but set that of complete We we end
while XXXX is earlier. will well sales measures our our establishing expansion I described and predictable of we've as allowing centers expansion team the the and both continue continue the that to plan, through of to the team effects pause to be before the through to grow we're at that Our described as point as more by reimbursement test volume
mentioned, previously in have test in centers we located -- now have we XX states. different centers eleven I located
them which at a resources we You have nurse A had I point, different here. -- but and we allocation we called see there. to be thought with the of a Seattle, a can would we we'll practitioner our regard of go notes, managing did in cumbersome became hurdles couple elsewhere. there center bit better we regulatory back
this by so. Since added much a for see we're the as an continue can centers very and and do our to of you Chicago, additional three in we there in previously, path that's opening Illinois good end shooting center announcement, we're described on last we we year a recent
talk me about really operations. our that the proud laboratory a made. quite we've bit Let progress We're little of
performing of of been Diagnostics DX this or we've If Lucid independent Lucid way our one in the and say that being test you fully our to year I with aspects we've and personal gradually Lab own laboratory. now February was now labs and probably the recall may transitioned in working live can all
arrives extracted our highlight as You can improved that ability DNA but I'd through extract in see and all a sample there. multiple that just I go from parameters to here the efficiencies. the substantial I thought we've it the few, here, won't details
has aspect we're see costly. incredibly substantial the critical test actually can of which conversion garnering DNA more a that the of is performance amounts like which You test and an phase, step obscure and impact and self the sample, has somewhat time consuming by even by on been per very
patient team been variety that get continue that efficiencies down. physician able go turnaround and see just from couple the and a to automation. savings is cost a team that our also needs, can cost to decreasing really are The resources time decreased including of through months the and dramatically view important has has extract facing that times overall and the You to a there for well and the in of of into opportunities bodes point
we You some but the a growing of as we've were turnaround when couple record the to can for see increased over there which months, lab is decreased days us. in times time took now the pains early six
little talk that. and I a we think are strategy bit reimbursement about I'll with where our
the about representing relates near important If term see versus Medicare. securing date as that from for XX%. of for to skew only Medicare test really that the you private you coverage can performed as it look the the left, reimbursement payer balance payers to at is we at That opportunities and for private look determination upper and heavily local payers with Medicare Medicaid mix are towards our
news. X is the second that year on and a draft we foundational that commented that, on working on quarter the dozen that. us LCD. included of coverage The of update other the in quick reviewing on do determination local Multi that They still lot comments have which a a that are group, entities it occurred A about really of
that. to response any heard haven't We
with were call -- local will for time required productive. the actual coverage did those foundational about that our data plan appropriate at clinical that's EsoGuard the and fruitful to coverage call weren't a of utility but to translate when determination, LCD required we of an into Although be the final discuss but have tribulation collecting for quite a have conversations we with allowed we did to the team them, type talk a
that with working that bit for through in covered in fruit, way all to the so that with you about factor a do have talk start organizations more we and that have lower to steadily do payer discussions private that. way hanging collecting down see to directors clinical directors multiple national so I'll way pairs through secondary our from little a both increasing side, with The and we're plans the and as the plans. On we side are PPOs utility are that are and the preferred but to private which data lives start remains chart further the security with payroll key data collecting medical to ongoing we believe we from forth retired start continue securing a through it position vetting the and we been on this here should more -- plan our later, existing medical able plan networks being of it's we've and Medicare
of last the that discussed we claims are the over claims set we that first year, have we the way the took claims variety through build or that on process just that back ultimately, when have a and all certificate started entire laboratory claims adjudications through to payment entity filling then for we start thousand as behalf been part and clear the August. and revenues several February place was in of of theoretically cycle in on goes our our so management we These and we're processes, completed the August behalf management in our partner, the which partner and time is own this Claim process was and we able in cycle to to did denial holding. once quarter, transition of including August, leading August launched to revenue submits forth, beginning new
to and denial. to you a entire payers that paid, described primer larger submitted. were process typically be important looking the to we we a pay -- up that secure a the meaningful forward for paid percentage the if once we work in appeal have claims that shown to can start of slide. important elements network place opportunity at we're and with is being it's after history, where those to payment, larger starting the on or have there contract. many So it now payer is the the but claims out particular appealed can to conversations If direct actually we charges and the denied, times of built that private conversations and works I've are their history the in extremely payment forth how actually in the of can just that on are securing all payer starting final as plans payment a is of for process before we build so out as these payment reimbursement an generate have claims denied, bit we so a substantive taken in so rate build be payment to little and having This also to obviously are or work on this to that various on at a directly, order
at of typically about we price list of the said, in payer see we include -- $XXXX, did the of XX% part of of payments, a is did, benefit have submitting started reflect these them some standard to that payments we but to second payments payments They $XXXX XX% these network We paid charge were which to gratifying full as are because I resulting a the out us majority that payments We the out the quarter. in start worthy few network do payer. rate, payments. network
you do are to network from in of network we next network going of we'll the closely the and percentage of we as better a another a look that give to need So payments enough securing we out contracts. the couple will but get tracking waiting yet as to and know quarters to couple how over data better forward don't sense of get really quarters have of claims to picture what paid we that, submitted
is key securing I've our for as clinical reimbursement utility. factor the So establishing several mentioned times,
this the active, about I these at several talked resources had are that but coming clinical are and BX, the -- two quarters studies that in won't and studies currently look earlier our but launched BX shifted if performance detail, So that these along. own internal we we've we substantially go over clinical through from studies utility you
enroll them. are starting patients in to We
mid-part have of should by of that at that soon we're engage year to We from on. to meaningful the quite patients XXXs NYU substantial and next study data amount the the utility start hopeful generating retrospective corporate that have has payers private of
predictability supplement decision portion we made better that and time screening transferred and to on to have frankly be couple to We're case As took currently with I to quarters -- the excellent the essay keep the and out, the improved been expect nice asset years that to data do the that previously, and we're have continuing an of until a and have will personnel, that that of a going the will Science from in that Translational Medicine we the strategic Paper EX hold of ago. performance to we we study such enrol regard pause test for so data we performing mentioned for strides the so since the piece the making we from our improving next studies significant now. of itself study of we couple control once close
bit and to we again, preparation of the things continuing mentioned be the we're best subjecting we're for collected improve the have benefiting to cash this from control essay. study, even the a and fact will because I essay the version As that purposes samples for cost delayed
There are studies other there. a out lot of
you investigators we're generate excited from to continue society, other studies, national them. see are cancer and and Those data enroll really whether be studies they'd right, it. positive far of and initiating American others that can On the DA institute ongoing
was it's just transferring team Finally, our our quick of about Want Dennis, long to very and manufacturing manufacturing. for EsoCheck. a to This before form process. but our a and a process comment completing handing of technical commend it over
volume by that manufacturing of capacity a kind in we high upward San the year and capacity So go a with year, this is provider fully volume this with add by TX our about month a a collection decreasing by company important high dictates of of the the manufacture regard Mexico, there at but at in devices about scalable of just in median device headquartered coastline to have with cost Diego will to XX% demand a will and transfer moving also plants to manufacturer that this just really of initial unit of EsoCheck began just line this last device per that, and we additional XX,XXX units facility million to but year. the can lines what's have as October
the unlimited really really, for term. So near
about on And pass that, it talk so with to to financials. our I'll Dennis
